A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants - IM027-041
Updated: 29 July, 2019 | ClinicalTrials.gov
Print Friendly Summary
Inclusion Criteria: - Signed Informed Consent. - Healthy participant, as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations. Exclusion Criteria: - Women of child bearing potentia (WOCBP), pregnant or breastfeeding. - History of significant cardiovascular disease. - Participants who have smoked or used smoking cessation or nicotine containing products within 3 months of the first dose of study. Other protocol defined inclusion/exclusion criteria could apply.